Psychopharmaka im Kindes- und Jugendalter

作者: Gerhard Libal , Klaus Schmeck

DOI: 10.1024/0040-5930.66.6.467

关键词:

摘要: Compared to adults, the use of psychopharmacological substances in childhood and adolescence is significantly more controversial. Often sensation-seeking media reports on negative effects treatments children adolescents intensify this controversy a regular basis. In addition, even pharmacologically trained experts--though frequently without expertise Child Adolescent Psychiatry--question seriousness thus demands for treatment psychiatric disorders adolescence. Considering background evidence based decisions pediatric psychopharmacology are utmost importance. Effective psychopharmacotherapy needs be distinguished from ineffective treatments. The pros cons such approaches ought weighted out carefully together with patients their families. aim article provide rational concise foundation clinicians treating as well point currently best selected child adolescent psychiatry.

参考文章(21)
Mark L Wolraich, Laura McGuinn, Melissa Doffing, Treatment of attention deficit hyperactivity disorder in children and adolescents: safety considerations. Drug Safety. ,vol. 30, pp. 17- 26 ,(2007) , 10.2165/00002018-200730010-00003
E. Taylor, M. D�pfner, J. Sergeant, P. Asherson, T. Banaschewski, J. Buitelaar, D. Coghill, M. Danckaerts, A. Rothenberger, E. Sonuga-Barke, H.-C. Steinhausen, A. Zuddas, European clinical guidelines for hyperkinetic disorder-first upgrade European Child & Adolescent Psychiatry. ,vol. 13, pp. 7- 30 ,(2004) , 10.1007/S00787-004-1002-X
Joseph Biederman, Attention-Deficit/Hyperactivity Disorder: A Selective Overview Biological Psychiatry. ,vol. 57, pp. 1215- 1220 ,(2005) , 10.1016/J.BIOPSYCH.2004.10.020
Alisa K. Christman, Joli D. Fermo, John S. Markowitz, Atomoxetine, a novel treatment for attention-deficit-hyperactivity disorder. Pharmacotherapy. ,vol. 24, pp. 1020- 1036 ,(2004) , 10.1592/PHCO.24.11.1020.36146
Jeffrey A Bridge, Satish Iyengar, Cheryl B Salary, Rémy P Barbe, Boris Birmaher, Harold Alan Pincus, Lulu Ren, David A Brent, None, Clinical Response and Risk for Reported Suicidal Ideation and Suicide Attempts in Pediatric Antidepressant Treatment: A Meta-analysis of Randomized Controlled Trials JAMA. ,vol. 297, pp. 1683- 1696 ,(2007) , 10.1001/JAMA.297.15.1683
Julie M Zito, Daniel J Safer, Lolkje TW de Jong-van den Berg, Katrin Janhsen, Joerg M Fegert, James F Gardner, Gerd Glaeske, Satish C Valluri, A three-country comparison of psychotropic medication prevalence in youth Child and Adolescent Psychiatry and Mental Health. ,vol. 2, pp. 26- 26 ,(2008) , 10.1186/1753-2000-2-26
Thomas Jans, Susanne Walitza, Andreas Warnke, Zwangsstörungen bei Kindern und Jugendlichen Praxis Der Kinderpsychologie Und Kinderpsychiatrie. ,vol. 57, pp. 429- 456 ,(2008) , 10.13109/PRKK.2008.57.6.429
Ian Goodyer, Bernadka Dubicka, Paul Wilkinson, Raphael Kelvin, Chris Roberts, Sarah Byford, Siobhan Breen, Claire Ford, Barbara Barrett, Alison Leech, Justine Rothwell, Lydia White, Richard Harrington, Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trial BMJ. ,vol. 335, pp. 142- 142 ,(2007) , 10.1136/BMJ.39224.494340.55
Daniel A. Geller, Joseph Biederman, S. Evelyn Stewart, Benjamin Mullin, Andrés Martin, Thomas Spencer, Stephen V. Faraone, Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. American Journal of Psychiatry. ,vol. 160, pp. 1919- 1928 ,(2003) , 10.1176/APPI.AJP.160.11.1919